Injective Options Launches on Testnet With Six Markets

High attention and emotional sentiment detected.

The project frames Injective Options as infrastructure, not just another exchange. It supports fully backed calls and puts across six initial markets. Native Injective USDC backs every contract as collateral.

What Injective Options Actually Is

An option gives the holder the right, not the obligation, to buy or sell an asset at a set price. Injective Options is a shared layer for creating and trading these contracts directly on-chain.

So developers can plug into it rather than rebuild matching, margining, and settlement from scratch. That reuse is the core of the pitch.

Traditional venues like Deribit mostly match options off-chain. Meanwhile, many on-chain rivals use pooled AMM models that split liquidity. Injective takes a different route.

The chain already runs a native order book module with shared liquidity across apps. Options now join spot, perpetuals, and real-world asset markets on the same rails.

How It Differs From Injective’s Binary Options

Injective is not new to options. A binary options module has run on the chain since 2022. Apps such as Frontrunner used it for prediction-market style bets.

But binary options only pay a fixed amount on a yes or no outcome. By contrast, these new calls and puts track an underlying price against a strike. So the payoff scales with the market, which suits hedging and structured products.

Six Markets Backed by Native USDC

The testnet launch opens with six markets. They are SICI, US500, US Tech, Gold, Silver, and Oil.

SICI is the Super Intelligence Compute Index, the first on-chain AI compute index. US500 tracks the top 500 US companies. US Tech covers the top 100 US technology firms. Gold, silver, and oil round out the list.

Native Injective USDC fully backs every option. Full backing means real collateral sits behind each contract. As a result, counterparty risk drops compared with partly backed systems.

Injective notes that native USDC now works as a canonical standard across more than 20 blockchains. That choice keeps collateral liquid and familiar for traders.

Why Injective Options Follows SICI by a Day

The timing is deliberate. Injective launched SICI as a mainnet perpetual on 26 October 2026, one day earlier. That blog post had already flagged a new primitive arriving within days.

LO:TECH prices SICI, a five-GPU weighted index, from compute marketplaces. It trades with up to 10x leverage and USDC margin. So options on SICI now let traders hedge or speculate on AI compute costs on-chain.

Consider a data center exposed to rising GPU prices. It could buy SICI calls to offset that risk. This is exactly the kind of hedge the primitive aims to enable.

What Developers and Institutions Get

Injective aims the primitive at three groups. First, developers can launch white-label options venues or new derivatives protocols. Second, institutions can build customized hedging products. Finally, users can trade or write options directly on-chain.

In its own words, the team is positioning this as shared infrastructure for an ecosystem of options protocols. The quote below sums up the framing.

Injective isn’t building just another options exchange. It’s introducing the composable infrastructure for an entire ecosystem of options protocols to thrive and interact with financial primitives across the onchain universe.

What Injective Options Has Not Confirmed Yet

Key mechanics stay unstated for now. Injective has not said whether the options use European or American style exercise. Nor has it detailed strikes, expiries, or the fee model.

The matching model is also unclear. Prior Injective derivatives run through its order book with sealed batch auctions. Still, Injective has not yet confirmed whether options follow the same design.

No mainnet date exists yet. No contract addresses or market IDs have appeared in primary sources. So far, no third-party app has confirmed an integration.

Early Reaction Stays Measured

Response on X leaned positive but light. Supporters restated the six markets and the infrastructure angle. Still, engagement stayed modest relative to the account’s reach.

No major outlet such as CoinDesk or The Block had covered the launch by that evening. The gap looks like timing, since the news broke the same day. For now, no vaporware pushback has surfaced in primary channels.

What Comes Next for Injective Options

For now, Injective Options sits on testnet, not mainnet. So builders can test it, but live liquidity and open interest will come later.

INJ traded near $8 across 26 and 27 October, with no sharp move tied to the news. Testnet features still need mainnet delivery and real depth to matter.

The next signals to watch are a mainnet date, confirmed integrations, and published contract details. If those land, Injective Options could extend the chain’s derivatives stack well beyond perpetuals.

This article is for informational purposes only and is not financial advice. Always do your own research before trading or writing options.